Neuro-bio’s seminal paper has been accepted.

We are delighted to announce that our seminal paper A novel process driving Alzheimer’s validated in a mouse model: therapeutic potential’ has been accepted by the peer-reviewed journal  Alzheimer’s & Dementia: Translational Research & Clinical Interventions.  At last,  our disruptive approach to Alzheimer’s, proof of concept of our basic hypothesis, and efficacy of our novel drug NBP14, will have a wider public platform. We see this MS as a real milestone since it brings together previously disparate reports in the literature for mapping the steps in the neurodegenerative process and suggests a first-in-class drug treatment, now acknowledged by the MHRA as completely innovative. Although the manuscript is under embargo for 6 weeks, we are currently planning a press conference in early April. More details will be available as plans become clearer, but please watch this space!